TITLE

Markers of disease activity in chronic hepatitis B virus infection

AUTHOR(S)
Yalcin, Kendal; Degertekin, Halil; Yildiz, Fetin; Celik, Yusuf
PUB. DATE
February 2003
SOURCE
Clinical & Investigative Medicine;Feb2003, Vol. 26 Issue 1, p27
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on a study which examined indicators of hepatitis B virus (HBV) activity in chronic HBV patients. Method; Results; Conclusions.
ACCESSION #
9321818

 

Related Articles

  • A qualitative study of hepatitis B carriers' understanding of their chronic infection. Ngiap-Chuan Tan; Seng-Lian Cheah; Eng Kiong Teo; Kwok, Violet // Asia Pacific Family Medicine;Jul2005, Vol. 4, Special section p1 

    Aim: : This study aimed to determine hepatitis B (HBV) carriers' understanding of the etiology, pathology, monitoring and therapy of their chronic disease. Methods: A qualitative study using focus group discussion (FGD) and a semi-structured guideline to explore HBV carriers' understanding of...

  • Detection of hepatitis B virus genotype A3 and primary drug resistance mutations in African immigrants with chronic hepatitis B in Spain. Bottecchia, Marcelle; Madejón, Antonio; Puente, Sabino; García-Samaniego, Javier; Rivas, Pablo; Herrero, Dolores; Soriano, Vincent // Journal of Antimicrobial Chemotherapy (JAC);Mar2011, Vol. 66 Issue 3, p641 

    Background Universal vaccination and antiviral therapy have reduced chronic hepatitis B virus (HBV) in natives in the Western world. However, immigration from high HBV endemic areas continues to maintain a relatively stable prevalence of chronic hepatitis B in most developed countries. Methods...

  • Factors associated with spontaneous HBsAg clearance in chronic hepatitis B patients followed at a university hospital. Ferreira, Sandro C.; Chachá, Silvana G. F.; Souza, Fernanda F.; Teixeira, Andreza C.; Santana, Rodrigo C.; Villanova, Márcia G.; Zucoloto, Sérgio; Ramalho, Leandra N.; Perdoná, Gleici S. C.; Passos, Afonso D. C.; Martinelli, Ana L. C. // Annals of Hepatology: Official Journal of the Mexican Associatio;Nov/Dec2014, Vol. 13 Issue 6, p762 

    Introduction. Few studies have evaluated the factors involved in the spontaneous HBsAg seroclearance in patients with chronic hepatitis B (HBV) followed up on a long-term basis from areas with a low prevalence of HBV infection. We aimed to determine the rate of spontaneous HBsAg seroclearance...

  • Short-term intravenous interferon therapy for chronic hepatitis B. Okushin, Hiroaki; Ohnishi, Toru; Morii, Kazuhiko; Uesaka, Koichi; Yuasa, Shiro; Abraham, Philip; Rippe, Richard A. // World Journal of Gastroenterology;5/21/2008, Vol. 14 Issue 19, p3038 

    AIM: To investigate the therapeutic efficacy of short-term, multiple daily dosing of intravenous interferon (IFN) in patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B. METHODS: IFN-β was intravenously administered at a total dose of 102 million international units (MIU)...

  • Assessment of Clinical Utility of Low and High Normal Alanine Aminotransferase Values in Patients with Chronic Hepatitis B Virus Infection in Bangladesh. Al-Mahtab, Mamun; Rahman, Salimur; Fazle Akbad, Sheikh Mohammad; Kamal, Mohammad; Islam Khan, Mohammad Sakirul // Digestion;2010, Vol. 83 Issue 1/2, p60 

    Background/Aims: There is a lack of consensus about the currently accepted range of normal values for serum alanine aminotransferase (ALT) levels because some investigators have claimed that the true values are significantly lower than those listed by kit manufacturers. Methods: A total of 255...

  • Hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Liaw, Yun-Fan // Journal of Gastroenterology;2002 Supplement 13, Vol. 37, p65 

    Because hepatitis B virus (HBV) and hepatitis C virus (HCV) have the same transmission routes, dual infection may occur and even persist in the same patient. The reported series on seroprevalence of HCV indicate that HCV is found in more than 10% of HBV-infected patients worldwide. HCV...

  • HIV�HBV Coinfection � A Global Challenge. Kourtis, Athena P.; Jamieson, Denise J.; Bulterys, Marc; Hu, Dale J. // New England Journal of Medicine;5/10/2012, Vol. 366 Issue 19, p1749 

    The article discusses the negative effects of coinfection with human immunodeficiency virus type 1 (HIV-1) and hepatitis B virus (HBV). Both viruses can cause chronic disease, cancer and death and are not eliminated with the use of current therapies. An overview of high HBV infection rates which...

  • Dynamics of Hepatitis B Virus Quasispecies in Association with Nucleos(t)ide Analogue Treatment Determined by Ultra-Deep Sequencing. Nishijima, Norihiro; Marusawa, Hiroyuki; Ueda, Yoshihide; Takahashi, Ken; Nasu, Akihiro; Osaki, Yukio; Kou, Tadayuki; Yazumi, Shujiro; Fujiwara, Takeshi; Tsuchiya, Soken; Shimizu, Kazuharu; Uemoto, Shinji; Chiba, Tsutomu // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Background and Aims: Although the advent of ultra-deep sequencing technology allows for the analysis of heretoforeundetectable minor viral mutants, a limited amount of information is currently available regarding the clinical implications of hepatitis B virus (HBV) genomic heterogeneity....

  • Therapeutic options for chronic hepatitis B in 2013. Asselah, Tarik; Marcellin, Patrick // Hot Topics in Viral Hepatitis;2013, Vol. 9 Issue 28, p8 

    In recent years, many improvements have been made in prevention and treatment of hepatitis B virus (HBV) infection--one of the major causes of chronic hepatic diseases: cirrhosis and hepatocellular carcinoma (HCC). The aim of this therapy is preventing the progression of the disease through...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics